Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line

作者: Fusako Kito , Rieko Oyama , Yoko Takai , Marimu Sakumoto , Kumiko Shiozawa

DOI: 10.1007/S13577-018-0199-9

关键词:

摘要: Synovial sarcoma is an aggressive mesenchymal malignancy characterized by unique gene fusions. Tissue culture cells are essential tools for further understanding tumorigenesis and anti-cancer drug development; however, only a limited number of well-characterized synovial cell lines exist. Thus, the objective this study was to establish patient-derived line. We established line from tumor tissue isolated 72-year-old female patient. Prepared were analyzed presence fusions fluorescence in situ hybridization, RT-PCR, karyotyping. In addition, resulting viability, short tandem repeat, colony spheroid formation, invasion analyses. Differences enrichment between primary examined mass spectrometric protein expression profiling KEGG pathway analysis. Our analyses revealed that NCC–SS1–C1 harbored SS18–SSX1 fusion typical similar proteomics profiles. vitro also confirmed invasive, colony-forming, spheroid-forming potentials. Moreover, screening with chemotherapeutic agents tyrosine kinase inhibitors doxorubicin, subset inhibitors, several molecular targeting drugs markedly decreased viability. Results present support will be effective tool research.

参考文章(23)
George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur Staddon, Mohammed Milhem, Anthony Elias, Kristen Ganjoo, Hussein Tawbi, Brian A. Van Tine, Alexander Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok V. Parekh, Robert G. Maki, Shreyaskumar R. Patel, Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Journal of Clinical Oncology. ,vol. 34, pp. 786- 793 ,(2016) , 10.1200/JCO.2015.62.4734
Jan M. Siehl, Eckhard Thiel, Alexander Schmittel, Gero Hütter, Peter M. Deckert, Hubert Szelényi, Ulrich Keilholz, Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma Cancer. ,vol. 104, pp. 611- 617 ,(2005) , 10.1002/CNCR.21211
Toshihiko Doi, Yan Ma, Aruna Dontabhaktuni, Cornelia Nippgen, Johannes Nippgen, Atsushi Ohtsu, Phase I study of olaratumab in Japanese patients with advanced solid tumors Cancer Science. ,vol. 105, pp. 862- 869 ,(2014) , 10.1111/CAS.12444
Fritz C. Eilber, Sarah M. Dry, Diagnosis and management of synovial sarcoma. Journal of Surgical Oncology. ,vol. 97, pp. 314- 320 ,(2008) , 10.1002/JSO.20974
Jean-Yves Blay, Michael G. Leahy, Binh Bui Nguyen, Shreyaskumar R. Patel, Peter Hohenberger, Armando Santoro, Arthur P. Staddon, Nicolas Penel, Sophie Piperno-Neumann, Andrew Hendifar, Pilar Lardelli, Antonio Nieto, Vicente Alfaro, Sant P. Chawla, Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas European Journal of Cancer. ,vol. 50, pp. 1137- 1147 ,(2014) , 10.1016/J.EJCA.2014.01.012
Jacek R Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj, Matthias Mann, Universal sample preparation method for proteome analysis Nature Methods. ,vol. 6, pp. 359- 362 ,(2009) , 10.1038/NMETH.1322
Takanobu Otsuka, Junya Toguchida, Kazuo Hayakawa, Makoto Ikeya, Makoto Fukuta, Knut Woltjen, Sakura Tamaki, Naoko Takahara, Tomohisa Kato, Shingo Sato, Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells. Biochemical and Biophysical Research Communications. ,vol. 432, pp. 713- 719 ,(2013) , 10.1016/J.BBRC.2013.01.003
Gunar K. Zagars, Matthew T. Ballo, Peter W. T. Pisters, Raphael E. Pollock, Shreyaskumar R. Patel, Robert S. Benjamin, Harry L. Evans, Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. ,vol. 97, pp. 2530- 2543 ,(2003) , 10.1002/CNCR.11365
T Ren, Q Lu, W Guo, Z Lou, X Peng, G Jiao, Y Sun, The clinical implication of SS18 -SSX fusion gene in synovial sarcoma British Journal of Cancer. ,vol. 109, pp. 2279- 2285 ,(2013) , 10.1038/BJC.2013.547
George D. Demetri, Sant P. Chawla, Isabelle Ray-Coquard, Axel Le Cesne, Arthur P. Staddon, Mohammed M. Milhem, Nicolas Penel, Richard F. Riedel, Binh Bui-Nguyen, Lee D. Cranmer, Peter Reichardt, Emmanuelle Bompas, Thierry Alcindor, Daniel Rushing, Yang Song, Ruey-min Lee, Scot Ebbinghaus, Joseph E. Eid, John W. Loewy, Frank G. Haluska, Pierre F. Dodion, Jean-Yves Blay, Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy Journal of Clinical Oncology. ,vol. 31, pp. 2485- 2492 ,(2013) , 10.1200/JCO.2012.45.5766